If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Line Nederby is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Polycythemia Vera Medicine & Life Sciences
Flow cytometry Chemical Compounds
Residual Neoplasm Medicine & Life Sciences
Flow Cytometry Medicine & Life Sciences
Stem cells Chemical Compounds
Neoplasms Medicine & Life Sciences
Cell Biology Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

Blood natural killer cells as a new, independent prognostic factor in recurrent ovarian cancer

Henriksen, J. R., Nederby, L., Donskov, F., Waldstrøm, M., Adimi, P., Jakobsen, A. & Dahl Steffensen, K., 29. Aug 2019.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

46 Downloads (Pure)

Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer

Hansen, T. F., Nederby, L., Zedan, A. H., Mejlholm, I., Henriksen, J. R., Dahl Steffensen, K., Thomsen, C. B., Raunkilde, L., Jensen, L. H. & Jakobsen, A., Jul 2019, In : Translational Oncology. 12, 7, p. 968-972

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Neoplasms
Confidence Intervals
Interferon-gamma
Palliative Care
Ovarian Neoplasms

Natural killer cells and treatment effect in recurrent ovarian cancer

Henriksen, J. R., Nederby, L., Donskov, F., Jakobsen, A., Adimi, P., Waldstrøm, M. & Dahl Steffensen, K., 20. Sep 2019, In : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 29, Suppl. 3, p. A33 1 p., 59.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Open Access

Revisiting CLEC12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy

Bill, M., Aggerholm, A., Kjeldsen, E., Roug, A. S., Hokland, P. & Nederby, L., Mar 2019, In : British Journal of Haematology. 184, 5, p. 769-781

Research output: Contribution to journalJournal articleResearchpeer-review

Acute Myeloid Leukemia
Cytogenetics
Aldehyde Dehydrogenase
Rare Diseases
Leukemia
120 Downloads (Pure)

Case report: Exome sequencing identifies T-ALL with myeloid features as a IKZF1-struck early precursor T-cell malignancy

Hansen, M. C., Nederby, L., Kjeldsen, E., Petersen, M. A., Ommen, H. B. & Hokland, P., 1. Jan 2018, In : Leukemia Research Reports. 9, p. 1-4

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File